Company Filing History:
1 out of 16,338 
1 out of 3,684 
Years Active: 2006-2007
Title: Michael Ramaker: Innovator in Biotechnology
Introduction
Michael Ramaker is a notable inventor based in Greenville, DE (US). He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotides and methods for enhancing plant seed nutrition. With a total of 2 patents, his work has implications for both medical and agricultural advancements.
Latest Patents
Ramaker's latest patents include a novel polynucleotide encoding a unique acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3). This invention provides polynucleotides that encode MGAT3 polypeptides, along with vectors, host cells, antibodies, and methods for producing these polypeptides. The invention also outlines diagnostic and therapeutic methods for utilizing MGAT3 polypeptides in the treatment and prevention of diseases such as obesity. Another significant patent involves a nucleic acid fragment that encodes a plant methionine synthase gene. This invention aims to increase the methionine content in plant seeds, which is crucial for improving nutritional value.
Career Highlights
Throughout his career, Michael Ramaker has worked with prominent companies such as E.I. du Pont de Nemours and Company and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to develop and refine his innovative ideas in biotechnology.
Collaborations
Some of his notable coworkers include Saverio Carl Falco and Omolayo O Famodu. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.
Conclusion
Michael Ramaker's contributions to biotechnology through his patents and collaborations highlight his role as an innovator. His work continues to influence both medical and agricultural sectors, showcasing the importance of innovation in addressing contemporary challenges.